China Biotech Services Holdings Limited (8037.HK) Stock Competitors & Peer Comparison

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 2359.HK has a market cap of 455.9B. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 2359.HK trades at HK$159.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 2359.HK's P/E ratio is 20.18. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 2359.HK's ROE of +0.27%. Regarding short-term risk, 8037.HK is more volatile compared to 2359.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 2359.HK's competition here

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 2268.HK has a market cap of 70.7B. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 2268.HK trades at HK$55.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 2268.HK's P/E ratio is 44.75. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 2268.HK's ROE of +0.16%. Regarding short-term risk, 8037.HK is more volatile compared to 2268.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 2268.HK's competition here

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 6127.HK has a market cap of 34B. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 6127.HK trades at HK$25.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 6127.HK's P/E ratio is 32.69. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 6127.HK's ROE of +0.06%. Regarding short-term risk, 8037.HK is more volatile compared to 6127.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 6127.HK's competition here

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 9860.HK has a market cap of 2.7B. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 9860.HK trades at HK$3.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 9860.HK's P/E ratio is 85.56. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 9860.HK's ROE of N/A. Regarding short-term risk, 8037.HK is more volatile compared to 9860.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 9860.HK's competition here

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 2251.HK has a market cap of 1B. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 2251.HK trades at HK$10.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 2251.HK's P/E ratio is -5.60. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 2251.HK's ROE of -0.02%. Regarding short-term risk, 8037.HK is more volatile compared to 2251.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 2251.HK's competition here

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 2325.HK has a market cap of 380.5M. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 2325.HK trades at HK$0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 2325.HK's P/E ratio is -1.40. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 2325.HK's ROE of +0.00%. Regarding short-term risk, 8037.HK is more volatile compared to 2325.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 2325.HK's competition here

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 8247.HK has a market cap of 200.6M. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 8247.HK trades at HK$3.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 8247.HK's P/E ratio is -7.61. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 8247.HK's ROE of N/A. Regarding short-term risk, 8037.HK is more volatile compared to 8247.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 8247.HK's competition here

8037.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8037.HK stands at 644M. In comparison, 0928.HK has a market cap of 124M. Regarding current trading prices, 8037.HK is priced at HK$0.66, while 0928.HK trades at HK$0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8037.HK currently has a P/E ratio of -3.23, whereas 0928.HK's P/E ratio is 8.65. In terms of profitability, 8037.HK's ROE is -0.31%, compared to 0928.HK's ROE of +0.01%. Regarding short-term risk, 8037.HK is more volatile compared to 0928.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8037.HK.Check 0928.HK's competition here